ArticleViruses2022

Histone Deacetylase Inhibitor Panobinostat Benefits the Therapeutic Efficacy of Oncolytic Herpes Simplex Virus Combined with PD-1/PD-L1 Blocking in Glioma and Squamous Cell Carcinoma Models.

Yinglin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.